Cargando…
Predicting population: development and validation of a new predictive nomogram for evaluating medication nonadherence risk in a type 2 diabetes
BACKGROUND: Diabetes mellitus is a growing global health challenge and affects patients of all ages. Treatment aims to keep blood glucose levels close to normal and to prevent or delay complications. However, adherence to antidiabetic medicines is often unsatisfactory. PURPOSE: Here, we established...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932313/ https://www.ncbi.nlm.nih.gov/pubmed/35310157 http://dx.doi.org/10.7717/peerj.13102 |
_version_ | 1784671427955261440 |
---|---|
author | QiMuge, NaRen Fang, Xu Chang, Baocheng Li, Dong Mei Li, Yuanyuan |
author_facet | QiMuge, NaRen Fang, Xu Chang, Baocheng Li, Dong Mei Li, Yuanyuan |
author_sort | QiMuge, NaRen |
collection | PubMed |
description | BACKGROUND: Diabetes mellitus is a growing global health challenge and affects patients of all ages. Treatment aims to keep blood glucose levels close to normal and to prevent or delay complications. However, adherence to antidiabetic medicines is often unsatisfactory. PURPOSE: Here, we established and internally validated a medication nonadherence risk nomogram for use in Chinese type 2 diabetes mellitus (T2DM) patients. METHODS: This cross-sectional study was carried out from July–December 2020 on randomly selected T2DM patients visiting a diabetes clinic and included 753 participants. Adherence was analyzed based on an eight-item Morisky Medication Adherence Scale (MMAS-8). Other data, including patient demographics, treatment, complications, and comorbidities, were also collected on questionnaires. Optimization of feature selection to develop the medication nonadherence risk model was achieved using the least absolute shrinkage and selection operator regression model (LASSO). A prediction model comprising features selected from LASSO model was designed by applying multivariable logistic regression analysis. The decision curve analysis, calibration plot, and C-index were utilized to assess the performance of the model in terms of discrimination, calibration, and clinical usefulness. Bootstrapping validation was applied for internal validation. RESULTS: The prediction nomogram comprised several factors including sex, marital status, education level, employment, distance, self-monitoringofbloodglucose, disease duration, and dosing frequency of daily hypoglycemics (pills, insulin, or glucagon-like peptide-1). The model exhibited good calibration and good discrimination (C-index = 0.79, 95% CI [0.75–0.83]). In the validation samples, a high C-index (0.75) was achieved. Results of the decision curve analysis revealed that the nonadherence nomogram could be applied in clinical practice in cases where the intervention is decided at a nonadherence possibility threshold of 12%. CONCLUSION: The number of patients who adhere to anti-diabetes therapy was small. Being single male, having no formal education, employed, far from hospital, long disease duration, and taking antidiabetics twice or thrice daily, had significant negative correlation with medication adherence. Thus, strategies for improving adherence are urgently needed. |
format | Online Article Text |
id | pubmed-8932313 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | PeerJ Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89323132022-03-19 Predicting population: development and validation of a new predictive nomogram for evaluating medication nonadherence risk in a type 2 diabetes QiMuge, NaRen Fang, Xu Chang, Baocheng Li, Dong Mei Li, Yuanyuan PeerJ Diabetes and Endocrinology BACKGROUND: Diabetes mellitus is a growing global health challenge and affects patients of all ages. Treatment aims to keep blood glucose levels close to normal and to prevent or delay complications. However, adherence to antidiabetic medicines is often unsatisfactory. PURPOSE: Here, we established and internally validated a medication nonadherence risk nomogram for use in Chinese type 2 diabetes mellitus (T2DM) patients. METHODS: This cross-sectional study was carried out from July–December 2020 on randomly selected T2DM patients visiting a diabetes clinic and included 753 participants. Adherence was analyzed based on an eight-item Morisky Medication Adherence Scale (MMAS-8). Other data, including patient demographics, treatment, complications, and comorbidities, were also collected on questionnaires. Optimization of feature selection to develop the medication nonadherence risk model was achieved using the least absolute shrinkage and selection operator regression model (LASSO). A prediction model comprising features selected from LASSO model was designed by applying multivariable logistic regression analysis. The decision curve analysis, calibration plot, and C-index were utilized to assess the performance of the model in terms of discrimination, calibration, and clinical usefulness. Bootstrapping validation was applied for internal validation. RESULTS: The prediction nomogram comprised several factors including sex, marital status, education level, employment, distance, self-monitoringofbloodglucose, disease duration, and dosing frequency of daily hypoglycemics (pills, insulin, or glucagon-like peptide-1). The model exhibited good calibration and good discrimination (C-index = 0.79, 95% CI [0.75–0.83]). In the validation samples, a high C-index (0.75) was achieved. Results of the decision curve analysis revealed that the nonadherence nomogram could be applied in clinical practice in cases where the intervention is decided at a nonadherence possibility threshold of 12%. CONCLUSION: The number of patients who adhere to anti-diabetes therapy was small. Being single male, having no formal education, employed, far from hospital, long disease duration, and taking antidiabetics twice or thrice daily, had significant negative correlation with medication adherence. Thus, strategies for improving adherence are urgently needed. PeerJ Inc. 2022-03-15 /pmc/articles/PMC8932313/ /pubmed/35310157 http://dx.doi.org/10.7717/peerj.13102 Text en © 2022 QiMuge et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited. |
spellingShingle | Diabetes and Endocrinology QiMuge, NaRen Fang, Xu Chang, Baocheng Li, Dong Mei Li, Yuanyuan Predicting population: development and validation of a new predictive nomogram for evaluating medication nonadherence risk in a type 2 diabetes |
title | Predicting population: development and validation of a new predictive nomogram for evaluating medication nonadherence risk in a type 2 diabetes |
title_full | Predicting population: development and validation of a new predictive nomogram for evaluating medication nonadherence risk in a type 2 diabetes |
title_fullStr | Predicting population: development and validation of a new predictive nomogram for evaluating medication nonadherence risk in a type 2 diabetes |
title_full_unstemmed | Predicting population: development and validation of a new predictive nomogram for evaluating medication nonadherence risk in a type 2 diabetes |
title_short | Predicting population: development and validation of a new predictive nomogram for evaluating medication nonadherence risk in a type 2 diabetes |
title_sort | predicting population: development and validation of a new predictive nomogram for evaluating medication nonadherence risk in a type 2 diabetes |
topic | Diabetes and Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932313/ https://www.ncbi.nlm.nih.gov/pubmed/35310157 http://dx.doi.org/10.7717/peerj.13102 |
work_keys_str_mv | AT qimugenaren predictingpopulationdevelopmentandvalidationofanewpredictivenomogramforevaluatingmedicationnonadherenceriskinatype2diabetes AT fangxu predictingpopulationdevelopmentandvalidationofanewpredictivenomogramforevaluatingmedicationnonadherenceriskinatype2diabetes AT changbaocheng predictingpopulationdevelopmentandvalidationofanewpredictivenomogramforevaluatingmedicationnonadherenceriskinatype2diabetes AT lidongmei predictingpopulationdevelopmentandvalidationofanewpredictivenomogramforevaluatingmedicationnonadherenceriskinatype2diabetes AT liyuanyuan predictingpopulationdevelopmentandvalidationofanewpredictivenomogramforevaluatingmedicationnonadherenceriskinatype2diabetes |